Fig. 1From: Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancerCONSORT Diagram. CONSORT diagram showing details regarding the screening and treatment status. Patients were analysed if they received at least one dose of the experimental therapy. There were 32 patients who received the assigned treatment, of which 30 patients were evaluated for the primary endpointBack to article page